<DOC>
	<DOCNO>NCT02538718</DOCNO>
	<brief_summary>Ritodrine conventional approve tocolytics Korea ( KFDA ) , although withdrawn US market 10 year ago . As already know well , ritodrine many side effect tachycardia , hyperglycemia , pulmonary edema . When complication ritodrine appear , clinician consider use MgSO4 substitute , use off-the-label yet Korea . Facing discrepancy , investigator want compare efficacy safety MgSO4 ritodrine prove MgSO4 inferior ritodrine tocolytics . For singleton twin pregnancies 24+0weeks 34 complete week whose uterine contraction 4 20 minute period cervical ripen 25 % , investigator randomise Ritodrine group MgSO4 group . Then , investigator check change interval uterine contraction , degree pain appearance side effect treatment failure sign .</brief_summary>
	<brief_title>Efficacy Safety MgSO4 Tocolytics Compared Ritodrine Preterm Labor</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Ritodrine</mesh_term>
	<mesh_term>Tocolytic Agents</mesh_term>
	<criteria>Gestational age 24+0 34+6weeks singleton twin pregnancy preterm labor 4 time uterine contraction 20 minute 8 time 1 hour external tocography cervical dilatation 0 3cm cervical ripen 25 % , cervical length sonography 2cm triplet etc preterm premature rupture membrane cervical dilatation 3cm history cerclage operation pregnancy placenta previa severe hypertensive disease pregnancy history administration tocolytics 12 hour enrollment fever 38.0 ' c</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>